Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Disparities in access to and use of HIV-related health services in the Netherlands by migrant status and sexual orientation: a cross-sectional study among people recently diagnosed with HIV infection.

Bil JP, Zuure FR, Alvarez-Del Arco D, Prins JM, Brinkman K, Leyten E, van Sighem A, Burns F, Prins M.

BMC Infect Dis. 2019 Oct 29;19(1):906. doi: 10.1186/s12879-019-4477-2.

2.

Chronic hepatitis B and C infections in the Netherlands: estimated prevalence in risk groups and the general population.

Koopsen J, van Steenbergen JE, Richardus JH, Prins M, Op de Coul ELM, Croes EA, Heil J, Zuure FR, Veldhuijzen IK.

Epidemiol Infect. 2019 Jan;147:e147. doi: 10.1017/S0950268819000359.

3.

Hepatitis E virus seroprevalence and determinants in various study populations in the Netherlands.

Alberts CJ, Schim van der Loeff MF, Sadik S, Zuure FR, Beune EJAJ, Prins M, Snijder MB, Bruisten SM.

PLoS One. 2018 Dec 17;13(12):e0208522. doi: 10.1371/journal.pone.0208522. eCollection 2018.

4.

Usage of purchased self-tests for HIV infections among migrants living in the UK, France and the Netherlands: a cross-sectional study.

Bil JP, Prins M, Fakoya I, Volny-Anne A, Burns F, Zuure FR.

Sex Transm Infect. 2019 Dec;95(8):629-632. doi: 10.1136/sextrans-2018-053583. Epub 2018 Aug 31.

PMID:
30171170
5.

Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015.

Bil JP, Schrooders PA, Prins M, Kouw PM, Klomp JH, Scholing M, Huijbregts LP, Sonder GJ, Waegemaekers TC, de Vries HJ, Meijer W, Zuure FR, Tostmann A.

Euro Surveill. 2018 Mar;23(11). doi: 10.2807/1560-7917.ES.2018.23.11.17-00491.

6.

Usage of purchased self-tests for HIV and sexually transmitted infections in Amsterdam, the Netherlands: results of population-based and serial cross-sectional studies among the general population and sexual risk groups.

Bil JP, Prins M, Stolte IG, Dijkshoorn H, Heijman T, Snijder MB, Davidovich U, Zuure FR.

BMJ Open. 2017 Sep 21;7(9):e016609. doi: 10.1136/bmjopen-2017-016609.

7.

HIV testing week 2015: lowering barriers for HIV testing among high-risk groups in Amsterdam.

Bartelsman M, Joore IK, van Bergen JE, Hogewoning AA, Zuure FR, van Veen MG; HIV Transmission Elimination AMsterdam (H-TEAM) initiative.

BMC Infect Dis. 2017 Aug 1;17(1):529. doi: 10.1186/s12879-017-2617-0.

8.

The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms.

Willemse SB, Razavi-Shearer D, Zuure FR, Veldhuijzen IK, Croes EA, van der Meer AJ, van Santen DK, de Vree JM, de Knegt RJ, Zaaijer HL, Reesink HW, Prins M, Razavi H.

Neth J Med. 2015 Nov;73(9):417-31.

9.

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.

Gane E, Kershenobich D, Seguin-Devaux C, Kristian P, Aho I, Dalgard O, Shestakova I, Nymadawa P, Blach S, Acharya S, Anand AC, Andersson MI, Arendt V, Arkkila P, Baatarkhuu O, Barclay K, Ben-Ari Z, Bergin C, Bessone F, Blokhina N, Brunton CR, Choudhuri G, Chulanov V, Cisneros L, Croes EA, Dahgwahdorj YA, Daruich JR, Dashdorj NR, Davaadorj D, de Knegt RJ, de Vree M, Gadano AC, Gower E, Halota W, Hatzakis A, Henderson C, Hoffmann P, Hornell J, Houlihan D, Hrusovsky S, Jarčuška P, Kostrzewska K, Leshno M, Lurie Y, Mahomed A, Mamonova N, Mendez-Sanchez N, Mossong J, Norris S, Nurmukhametova E, Oltman M, Oyunbileg J, Oyunsuren Ts, Papatheodoridis G, Pimenov N, Prins M, Puri P, Radke S, Rakhmanova A, Razavi H, Razavi-Shearer K, Reesink HW, Ridruejo E, Safadi R, Sagalova O, Sanchez Avila JF, Sanduijav R, Saraswat V, Schréter I, Shah SR, Shevaldin A, Shibolet O, Silva MO, Sokolov S, Sonderup M, Souliotis K, Spearman CW, Staub T, Stedman C, Strebkova EA, Struck D, Sypsa V, Tomasiewicz K, Undram L, van der Meer AJ, van Santen D, Veldhuijzen I, Villamil FG, Willemse S, Zuckerman E, Zuure FR, Prabdial-Sing N, Flisiak R, Estes C.

J Viral Hepat. 2015 Jan;22 Suppl 1:46-73. doi: 10.1111/jvh.12352.

PMID:
25560841
10.

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.

Hatzakis A, Chulanov V, Gadano AC, Bergin C, Ben-Ari Z, Mossong J, Schréter I, Baatarkhuu O, Acharya S, Aho I, Anand AC, Andersson MI, Arendt V, Arkkila P, Barclay K, Bessone F, Blach S, Blokhina N, Brunton CR, Choudhuri G, Cisneros L, Croes EA, Dahgwahdorj YA, Dalgard O, Daruich JR, Dashdorj NR, Davaadorj D, de Knegt RJ, de Vree M, Estes C, Flisiak R, Gane E, Gower E, Halota W, Henderson C, Hoffmann P, Hornell J, Houlihan D, Hrusovsky S, Jarčuška P, Kershenobich D, Kostrzewska K, Kristian P, Leshno M, Lurie Y, Mahomed A, Mamonova N, Mendez-Sanchez N, Norris S, Nurmukhametova E, Nymadawa P, Oltman M, Oyunbileg J, Oyunsuren Ts, Papatheodoridis G, Pimenov N, Prabdial-Sing N, Prins M, Radke S, Rakhmanova A, Razavi-Shearer K, Reesink HW, Ridruejo E, Safadi R, Sagalova O, Sanchez Avila JF, Sanduijav R, Saraswat V, Seguin-Devaux C, Shah SR, Shestakova I, Shevaldin A, Shibolet O, Silva MO, Sokolov S, Sonderup M, Souliotis K, Spearman CW, Staub T, Stedman C, Strebkova EA, Struck D, Sypsa V, Tomasiewicz K, Undram L, van der Meer AJ, van Santen D, Veldhuijzen I, Villamil FG, Willemse S, Zuckerman E, Zuure FR, Puri P, Razavi H.

J Viral Hepat. 2015 Jan;22 Suppl 1:26-45. doi: 10.1111/jvh.12351.

PMID:
25560840
11.

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.

Saraswat V, Norris S, de Knegt RJ, Sanchez Avila JF, Sonderup M, Zuckerman E, Arkkila P, Stedman C, Acharya S, Aho I, Anand AC, Andersson MI, Arendt V, Baatarkhuu O, Barclay K, Ben-Ari Z, Bergin C, Bessone F, Blach S, Blokhina N, Brunton CR, Choudhuri G, Chulanov V, Cisneros L, Croes EA, Dahgwahdorj YA, Dalgard O, Daruich JR, Dashdorj NR, Davaadorj D, de Vree M, Estes C, Flisiak R, Gadano AC, Gane E, Halota W, Hatzakis A, Henderson C, Hoffmann P, Hornell J, Houlihan D, Hrusovsky S, Jarčuška P, Kershenobich D, Kostrzewska K, Kristian P, Leshno M, Lurie Y, Mahomed A, Mamonova N, Mendez-Sanchez N, Mossong J, Nurmukhametova E, Nymadawa P, Oltman M, Oyunbileg J, Oyunsuren Ts, Papatheodoridis G, Pimenov N, Prabdial-Sing N, Prins M, Puri P, Radke S, Rakhmanova A, Razavi H, Razavi-Shearer K, Reesink HW, Ridruejo E, Safadi R, Sagalova O, Sanduijav R, Schréter I, Seguin-Devaux C, Shah SR, Shestakova I, Shevaldin A, Shibolet O, Sokolov S, Souliotis K, Spearman CW, Staub T, Strebkova EA, Struck D, Tomasiewicz K, Undram L, van der Meer AJ, van Santen D, Veldhuijzen I, Villamil FG, Willemse S, Zuure FR, Silva MO, Sypsa V, Gower E.

J Viral Hepat. 2015 Jan;22 Suppl 1:6-25. doi: 10.1111/jvh.12350.

PMID:
25560839
12.

Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review.

Zuure FR, Urbanus AT, Langendam MW, Helsper CW, van den Berg CH, Davidovich U, Prins M.

BMC Public Health. 2014 Jan 22;14:66. doi: 10.1186/1471-2458-14-66. Review.

13.

Screening for hepatitis B and C in first-generation Egyptian migrants living in the Netherlands.

Zuure FR, Bouman J, Martens M, Vanhommerig JW, Urbanus AT, Davidovich U, van Houdt R, Speksnijder AG, Weegink CJ, van den Hoek A, Prins M.

Liver Int. 2013 May;33(5):727-38. doi: 10.1111/liv.12131. Epub 2013 Mar 1.

PMID:
23448397
14.

Hepatitis C in the general population of various ethnic origins living in the Netherlands: should non-Western migrants be screened?

Urbanus AT, van de Laar TJ, van den Hoek A, Zuure FR, Speksnijder AG, Baaten GG, Heijman T, Vriend HJ, Op de Coul EL, Coutinho RA, Prins M.

J Hepatol. 2011 Dec;55(6):1207-14. doi: 10.1016/j.jhep.2011.02.028. Epub 2011 Apr 13.

PMID:
21703202
15.

Reasons for compliance or noncompliance with advice to test for hepatitis C via an internet-mediated blood screening service: a qualitative study.

Zuure FR, Heijman T, Urbanus AT, Prins M, Kok G, Davidovich U.

BMC Public Health. 2011 May 10;11:293. doi: 10.1186/1471-2458-11-293.

16.

Using mass media and the Internet as tools to diagnose hepatitis C infections in the general population.

Zuure FR, Davidovich U, Coutinho RA, Kok G, Hoebe CJ, van den Hoek A, Jansen PL, van Leeuwen-Gilbert P, Verheuvel NC, Weegink CJ, Prins M.

Am J Prev Med. 2011 Mar;40(3):345-52. doi: 10.1016/j.amepre.2010.11.019.

PMID:
21335268
17.

Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies.

van den Berg CH, van de Laar TJ, Kok A, Zuure FR, Coutinho RA, Prins M.

J Viral Hepat. 2009 Aug;16(8):568-77. doi: 10.1111/j.1365-2893.2009.01105.x. Epub 2009 Feb 23.

18.

[Hepatitis C in the Netherlands: sparse data on the current prevalence and the necessity for epidemiological studies and innovative methods for detecting infected individuals].

Kok A, Zuure FR, Weegink CJ, Coutinho RA, Prins M.

Ned Tijdschr Geneeskd. 2007 Oct 27;151(43):2367-71. Review. Dutch.

PMID:
18019212

Supplemental Content

Loading ...
Support Center